Canada Breast Cancer Diagnostics And Therapeutics Market Share 2019 Growth Challenges, Opportunities and Future Trends 2025
Canada breast cancer diagnostics and therapeutics market are estimated to grow significantly at a CAGR of 9.1% during the forecast period. The factors that influence the market growth in Canada include increasing the screening test for breast cancer and prevalence due to changes in life style. Breast cancer is the second leading cause of mortality in Canada. The incidence rate of breast cancer in Canada slightly increases with the increase in years. According to the Canadian Cancer Society about 26,300 women diagnosed with breast cancer in 2017. This accounts for 25% of all new cancer cases in women. The mortality due to breast cancer was about 5,000, which is 13% of all cancer mortality in women. On average 72 women in Canada were diagnosed and 14 women died with breast cancer every day. The breast cancer also happened in men about 230 men were diagnosed and mortality about 60 from breast cancer in 2017.
To Request a Sample of our Report on Canada
Breast Cancer Diagnostics And Therapeutics Market: https://www.omrglobal.com/request-sample/canada-breast-cancer-diagnostics-therapeutics-market
Canada breast cancer diagnosis and
therapeutics market are segmented on the basis of cancer type, diagnostics, and
therapeutics. In cancer type segment market is further classified into ductal
carcinoma in-situ (DCIS), invasive ductal carcinoma (IDC), triple negative
breast cancer (TNBC), inflammatory breast cancer and others. In diagnostics
technology, the segment market is further classified into mammography, biopsy,
position emission tomography/Computed tomography, ultrasound, and others. The therapeutics
technology segment market is further segregated into chemotherapy, hormone
therapy, targeted therapy, and others.
(Get 15% Discount on Buying this Report)
A
full Report of Canada Breast Cancer Diagnostics And Therapeutics Market is Available
@ https://www.omrglobal.com/industry-reports/canada-breast-cancer-diagnostics-therapeutics-market
Canada Breast Cancer
Diagnostics And Therapeutics Market Segmentation
By Cancer Type
·
Ductal Carcinoma In-Situ (DCIS)
·
Invasive Ductal Carcinoma (IDC)
·
Triple Negative Breast Cancer (TNBC)
·
Inflammatory Breast Cancer
·
Others (Invasive lobular carcinoma)
By Diagnostics
·
Mammography
·
Biopsy
·
PET/CET
·
Ultrasound
·
Others (MRI)
By Therapeutics
·
Chemotherapy
·
Hormone Therapy
·
Targeted Therapy
·
Others (Radiation Therapy, Surgery)
Company Profiles
·
AbbVie Inc.
·
Astellas Pharma Inc.
·
Bristol-Myers Squibb Co.
·
Eli Lilly and Co.
·
Hologic Inc.
·
Halozyme, Inc
·
Johnson & Johnson Services Inc.
·
Merck & Co., Inc.
·
Pfizer Inc.
·
Siemens Healthcare GmbH
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment